John C. Burnett

Molecular Biology · 2012

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom John C. Burnett trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Margaret S. Ebert
  2. John J. Rossi
  3. R. Garzon

Who trusts John C. Burnett overall

  1. R. Juliano

Papers from John C. Burnett's perspective

Ordered by how strongly the researchers John C. Burnett trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Variation in the reversibility of evolution (Nature)
  2. The promises and pitfalls of RNA-interference-based therapeutics (Nature)
  3. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy (Nature Biotechnology)
  4. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. (Cell)
  5. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles (Nature)
  6. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3 (Nature)
  7. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging (Proceedings of the National Academy of Sciences of the United States of America)
  8. Organization of Intracellular Reactions with Rationally Designed RNA Assemblies (Science)
  9. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. (Annual Review of Pharmacology and Toxicology)
  10. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. (Cell)

Their papers